ADAPTIMMUNE THERAPEUTICS PLC Cash and Cash Equivalents
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Cash and Cash Equivalents of $26.06 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-08-13
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $26.06M.
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $41.05M.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $91.14M.
- 2024-09-30: Cash and Cash Equivalents, at Carrying Value $116.74M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-06-30 | $26.06M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $41.05M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $91.14M 10-Q · filed 2025-08-13 |
| 2024-09-30 | $116.74M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $211.81M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $140.67M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $143.99M 10-K · filed 2025-03-24 |
| 2023-09-30 | $90.06M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $76.97M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $119.87M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $108.03M 10-K · filed 2024-03-06 |
| 2022-09-30 | $79.00M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $97.81M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $89.54M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $149.95M 10-K · filed 2023-03-06 |
| 2021-09-30 | $42.92M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $50.45M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $32.43M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $56.88M 10-K · filed 2022-03-14 |
| 2020-09-30 | $78.47M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $122.36M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $86.43M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $50.41M 10-K · filed 2021-02-25 |
| 2019-09-30 | $39.41M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $34.57M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $49.92M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $68.38M 10-K · filed 2020-02-27 |
| 2018-09-30 | $153.08M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $42.31M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $53.38M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $84.04M 10-K · filed 2019-02-27 |
| 2017-09-30 | $145.33M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $122.00M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $170.56M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $158.78M 10-K · filed 2018-03-15 |
| 2016-09-30 | $140.44M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $150.89M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $163.77M 10-Q · filed 2017-05-10 |
| 2015-12-31 | $194.26M 10-K · filed 2017-03-13 |
| 2015-09-30 | $217.22M 10-Q · filed 2016-11-10 |
| 2015-06-30 | $229.05M 10-K · filed 2017-03-13 |
| 2015-03-31 | $92.60M 10-Q · filed 2016-05-12 |
| 2014-12-31 | $101.66M 10-Q · filed 2016-11-10 |
| 2014-06-30 | $51.18M 8-K · filed 2016-07-08 |
| 2012-06-30 | $3.11M 8-K · filed 2016-07-08 |